Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
48,041,653
-
Number of holders
-
104
-
Total 13F shares, excl. options
-
22,145,073
-
Shares change
-
+7,132,410
-
Total reported value, excl. options
-
$640,866,936
-
Value change
-
+$216,554,424
-
Put/Call ratio
-
18%
-
Number of buys
-
66
-
Number of sells
-
-28
-
Price
-
$28.94
Significant Holders of BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share (BLFS) as of Q3 2020
115 filings reported holding BLFS - BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share as of Q3 2020.
BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share (BLFS) has 104 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22,145,073 shares
of 48,041,653 outstanding shares and own 46% of the company stock.
Largest 10 shareholders include Casdin Capital, LLC (5,840,107 shares), WASATCH ADVISORS INC (1,716,915 shares), VANGUARD GROUP INC (1,170,403 shares), Ranger Investment Management, L.P. (1,133,953 shares), BlackRock Inc. (1,111,337 shares), Park West Asset Management LLC (966,045 shares), AMERIPRISE FINANCIAL INC (908,196 shares), Russell Investments Group, Ltd. (892,488 shares), ROYCE & ASSOCIATES LP (845,116 shares), and TimesSquare Capital Management, LLC (524,200 shares).
This table shows the top 104 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.